6.46 USD
-0.04 (-0.62%)
Taking everything into account, PROF scores 4 out of 10 in our fundamental rating. PROF was compared to 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for PROF as it has an excellent financial health rating, but there are worries on the profitability. PROF is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year PROF has reported negative net income.
PROF had a negative operating cash flow in the past year.
In the past 5 years PROF always reported negative net income.
PROF had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
PROF has a Return On Assets of -93.00%. This is in the lower half of the industry: PROF underperforms 78.19% of its industry peers.
PROF's Return On Equity of -122.40% is on the low side compared to the rest of the industry. PROF is outperformed by 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93% | ||
| ROE | -122.4% | ||
| ROIC | N/A |
ROA(3y)-49.72%
ROA(5y)-41.04%
ROE(3y)-64.26%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of PROF (72.49%) is better than 81.38% of its industry peers.
In the last couple of years the Gross Margin of PROF has grown nicely.
The Profit Margin and Operating Margin are not available for PROF so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y2.85%
2. Health
2.1 Basic Checks
PROF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PROF has been increased compared to 1 year ago.
Compared to 5 years ago, PROF has more shares outstanding
Compared to 1 year ago, PROF has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.20, we must say that PROF is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.20, PROF is in line with its industry, outperforming 45.74% of the companies in the same industry.
PROF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.2 |
ROIC/WACCN/A
WACC7.64%
2.3 Liquidity
A Current Ratio of 4.18 indicates that PROF has no problem at all paying its short term obligations.
PROF's Current ratio of 4.18 is fine compared to the rest of the industry. PROF outperforms 72.34% of its industry peers.
PROF has a Quick Ratio of 3.34. This indicates that PROF is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.34, PROF is doing good in the industry, outperforming 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.18 | ||
| Quick Ratio | 3.34 |
3. Growth
3.1 Past
PROF shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
PROF shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.14%.
The Revenue has been growing by 20.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.58%
Revenue 1Y (TTM)59.14%
Revenue growth 3Y15.83%
Revenue growth 5Y20.67%
Sales Q2Q%86.76%
3.2 Future
Based on estimates for the next years, PROF will show a very strong growth in Earnings Per Share. The EPS will grow by 23.32% on average per year.
Based on estimates for the next years, PROF will show a very strong growth in Revenue. The Revenue will grow by 56.05% on average per year.
EPS Next Y-39.78%
EPS Next 2Y0.85%
EPS Next 3Y15.93%
EPS Next 5Y23.32%
Revenue Next Year51.68%
Revenue Next 2Y82.69%
Revenue Next 3Y73.26%
Revenue Next 5Y56.05%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PROF. In the last year negative earnings were reported.
Also next year PROF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PROF's earnings are expected to grow with 15.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.85%
EPS Next 3Y15.93%
5. Dividend
5.1 Amount
No dividends for PROF!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PROF (11/26/2025, 8:00:01 PM)
6.46
-0.04 (-0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners45.81%
Inst Owner Change-18.83%
Ins Owners17.71%
Ins Owner Change0%
Market Cap195.03M
Revenue(TTM)14.30M
Net Income(TTM)-39.34M
Analysts80
Price Target11.31 (75.08%)
Short Float %3.61%
Short Ratio7.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.31%
Min EPS beat(2)-40.1%
Max EPS beat(2)29.47%
EPS beat(4)2
Avg EPS beat(4)1.24%
Min EPS beat(4)-40.1%
Max EPS beat(4)42.88%
EPS beat(8)4
Avg EPS beat(8)-5.3%
EPS beat(12)7
Avg EPS beat(12)-2.31%
EPS beat(16)10
Avg EPS beat(16)0.34%
Revenue beat(2)1
Avg Revenue beat(2)-16.59%
Min Revenue beat(2)-38.03%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-15.52%
Min Revenue beat(4)-38.03%
Max Revenue beat(4)4.86%
Revenue beat(8)2
Avg Revenue beat(8)-13.01%
Revenue beat(12)2
Avg Revenue beat(12)-18.46%
Revenue beat(16)3
Avg Revenue beat(16)-19.86%
PT rev (1m)1.97%
PT rev (3m)0.14%
EPS NQ rev (1m)13.18%
EPS NQ rev (3m)-64.71%
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-39.64%
Revenue NQ rev (1m)6.3%
Revenue NQ rev (3m)-36.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 13.64 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.07 | ||
| P/tB | 6.09 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.34
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS0.47
BVpS1.06
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93% | ||
| ROE | -122.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.49% | ||
| FCFM | N/A |
ROA(3y)-49.72%
ROA(5y)-41.04%
ROE(3y)-64.26%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y2.85%
F-Score4
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.18 | ||
| Quick Ratio | 3.34 | ||
| Altman-Z | 0.2 |
F-Score4
WACC7.64%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.58%
EPS Next Y-39.78%
EPS Next 2Y0.85%
EPS Next 3Y15.93%
EPS Next 5Y23.32%
Revenue 1Y (TTM)59.14%
Revenue growth 3Y15.83%
Revenue growth 5Y20.67%
Sales Q2Q%86.76%
Revenue Next Year51.68%
Revenue Next 2Y82.69%
Revenue Next 3Y73.26%
Revenue Next 5Y56.05%
EBIT growth 1Y-27.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-26.37%
EBIT Next 3Y6.51%
EBIT Next 5Y28.76%
FCF growth 1Y-71.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.34%
OCF growth 3YN/A
OCF growth 5YN/A
PROFOUND MEDICAL CORP / PROF FAQ
What is the fundamental rating for PROF stock?
ChartMill assigns a fundamental rating of 4 / 10 to PROF.
What is the valuation status for PROF stock?
ChartMill assigns a valuation rating of 0 / 10 to PROFOUND MEDICAL CORP (PROF). This can be considered as Overvalued.
What is the profitability of PROF stock?
PROFOUND MEDICAL CORP (PROF) has a profitability rating of 1 / 10.
What is the earnings growth outlook for PROFOUND MEDICAL CORP?
The Earnings per Share (EPS) of PROFOUND MEDICAL CORP (PROF) is expected to decline by -39.78% in the next year.